Quick answer
Lyophilization freezes a peptide solution and removes the ice by sublimation under vacuum, leaving a dry, stable, porous cake.
- Stages: freezing, primary drying (sublimation), secondary drying (desorption)
- Why: removing water and mobility slows hydrolysis, deamidation and aggregation
- Handling: keep sealed and cold until use; warm before opening; reconstitution is one-way
- Calculation: mg/mL = vial mg ÷ diluent mL; use the calculator; lots on the CoA page
For laboratory research use only; not for human consumption.
Why water is the problem lyophilization solves
Water is both a peptide's biggest handling problem and, physically, the reason a solution to that problem exists at all. Lyophilization (freeze-drying) removes that water almost entirely, and it is the single process that makes shipping and storing research peptides at room-adjacent temperatures practical in the first place. This guide explains what happens inside the freeze-dryer, why the resulting powder is more stable, how to read the appearance of a finished vial and what handling rules follow.
Most peptide manufacturing ends in solution: after solid-phase synthesis, cleavage and preparative HPLC, the purified peptide is dissolved in a water-and-acetonitrile mixture, often with trifluoroacetic or acetic acid as the ion-pairing agent. That solution is dilute, reactive and impractical to ship. Freeze-drying turns it into a dry solid with the same peptide content and a fraction of the reactivity.
The physics: sublimation, not evaporation
The process begins by freezing the peptide solution solid, turning its water content into ice. The frozen material is then placed under a strong vacuum, and the shelf temperature is raised slightly, just enough that the ice sublimates, meaning it passes directly from solid to vapor without ever becoming liquid again. This is the critical part of the process: because the water never re-liquefies, the peptide is never re-exposed to the aqueous, high-mobility environment where most degradation reactions occur. A cold condenser in the chamber continuously traps the water vapor as it is produced, and a vacuum pump maintains low pressure.
Sublimation works only when the product stays below its critical temperature. If the product warms above the point at which the frozen matrix softens (the collapse temperature), it loses its structure and the cake shrinks or melts back. For that reason, cycle design depends on the formulation, which is why the same freeze-dryer runs different programs for different products.
The three stages of a freeze-drying cycle
| Stage | What happens | What is removed |
|---|---|---|
| Freezing | Solution is cooled until water forms ice and solutes concentrate between crystals | Nothing yet; sets the cake structure |
| Primary drying | Vacuum applied and heat added gently; ice sublimates | Roughly 90% or more of the water, as ice |
| Secondary drying | Temperature raised moderately; bound water desorbs | Water held on the peptide and cake surfaces |
Primary drying removes the bulk of the frozen water through sublimation and accounts for most of the process's duration. Secondary drying follows at a slightly warmer temperature and targets the small fraction of water that was never frozen, bound water molecules adhering to the peptide itself, through desorption rather than sublimation. What's left after both phases is a dry, porous, amorphous "cake" with very low residual moisture, typically in the low single-digit percentage range.
The freezing step deserves more attention than it usually gets. Slow cooling grows large ice crystals, which leave large pores and let vapor escape quickly during primary drying; fast cooling gives small crystals, a finer pore network and a longer drying time. Some formulations include an annealing hold above the glass transition to make crystal size more uniform. The choice affects both cake appearance and how readily the cake dissolves later.
Why this matters for stability
Peptides in solution are chemically far more reactive than the same compound in dry form. Water is a required participant in hydrolysis of the peptide backbone and in several other degradation pathways, and dissolved molecules also have far more freedom to move, interact and aggregate than molecules locked in a dry cake. By removing nearly all of that water without ever passing the peptide back through a liquid or high-heat phase, lyophilization produces a form that tolerates storage and shipping conditions a liquid formulation could not survive with the same stability.
| Degradation pathway | Needs water or mobility? | Effect of lyophilization |
|---|---|---|
| Backbone hydrolysis, including cleavage at Asp residues | Yes, water is a reactant | Largely suppressed |
| Deamidation of Asn and Gln | Yes | Slowed sharply |
| Aggregation and fibril formation | Needs molecular mobility | Mobility restricted in the dry solid |
| Oxidation of Met, Cys, Trp | Needs oxygen; accelerated in solution | Slower in the dry state; headspace still matters |
Lyophilization does not make a peptide immortal. Residual moisture, oxygen in the vial headspace, light and warm storage still drive slow degradation, which is why labelled storage conditions exist and why a well-made product is stored cold even in dry form.
What is in the cake besides the peptide
A lyophilized peptide vial is not pure peptide by mass. Counter-ions from purification, most often trifluoroacetate or acetate bound to basic side chains, can account for a substantial share of the weight, and residual water adds more. HPLC purity says how much of the peptide signal is the target; it does not report these. Net peptide content, measured separately, does. Some products also include bulking agents such as mannitol; if so, the supplier should state it, since it changes how label mass relates to peptide mass. See understanding HPLC purity for what the number does and does not tell you.
What it means for handling
Because the stability advantage depends on the material staying dry, a lyophilized vial should remain sealed and in appropriate cold storage (see storing research peptides) until a lab is actually ready to use it. Reintroducing water is a deliberate, one-way step: once a vial is reconstituted, typically with bacteriostatic water, the peptide re-enters the more reactive aqueous environment lyophilization was designed to avoid, and the solution's own stability clock starts running on a much shorter timeline than the dry powder's did.
- Let the vial reach room temperature before opening so condensation does not form on a cold cake.
- Keep the stopper intact and avoid repeated needle punctures of the closure when possible.
- Calculate the volume first. Concentration in mg/mL is vial mass divided by diluent volume; the calculator and the guide to reconstitution volume calculations work through examples.
- Aliquot after reconstitution if the solution will be used over time, to avoid repeated freeze-thaw cycles.
V8 research vials are supplied as lyophilized powder in sealed clear glass vials with the storage conditions stated on each product page: refrigerate at 2–8 °C, or −20 °C for the long term, away from heat, moisture and light. Example: the BPC-157 research vial.
What the finished cake looks like
A properly lyophilized vial should show a uniform, dry, slightly porous cake that fills roughly the same footprint the original solution occupied before freezing. Freeze-drying preserves the physical volume of the frozen material fairly well, since sublimation leaves the solid structure largely intact rather than collapsing it. Cake appearance varies legitimately, though: low-mass fills may appear as a thin film or a small puck, or even partly cling to the glass, without any quality problem. Features that deserve a closer look are:
- a shrunken, glassy or melted-looking cake, which can indicate collapse during drying or moisture uptake afterwards;
- a cake that has visibly pulled away from the vial wall in a way that looks wet or sticky;
- discoloration, which is not expected for most peptides;
- a broken or loose seal.
Any of these is worth flagging before that material goes into an experiment. Cloudy solution after adding diluent is a separate question, discussed in cloudy peptide vial after reconstitution. Appearance is a screening cue only; identity and purity are established by HPLC and mass spectrometry as described in HPLC vs. mass spectrometry, with batch records on the CoA page. You can also see the effect in practice on a third-party-tested BPC-157 vial.
Frequently asked questions
What is lyophilization in simple terms?
Freezing a solution and then removing the ice under vacuum by sublimation, so the water goes from solid straight to vapor and leaves a dry, porous cake.
Why are research peptides supplied freeze-dried?
Dry peptide is far less reactive than peptide in solution, because water drives hydrolysis and mobility drives aggregation. That allows shipping and storage that a liquid could not tolerate.
What is the difference between primary and secondary drying?
Primary drying sublimes the frozen water. Secondary drying desorbs the bound water that was never frozen, leaving low residual moisture.
Does freeze-drying remove all the water?
No. A small residual moisture, typically a few percent, remains. It, together with counter-ions, is part of why label mass is not pure peptide mass.
Is a small or odd-looking cake a defect?
Not necessarily. Small fills can look like a film or a puck. Shrunken, glassy or sticky-looking cakes are the signs that merit questions.
Why let a vial warm up before opening it?
A cold vial opened in humid air draws in condensation, which adds water to a cake whose stability depends on staying dry.
Does lyophilization mean room-temperature storage is fine?
It makes short excursions more tolerable, but labelled conditions still apply. V8 product pages specify 2–8 °C, with −20 °C for long-term storage.
How do I calculate a concentration after reconstitution?
Divide the vial mass in mg by the diluent volume in mL. A 10 mg vial in 2 mL is 5 mg/mL nominal. The calculator does this for any combination.
Research Use Only. For laboratory research use only; not for human consumption. This article is research education, not usage guidance.
References
- Understanding HPLC purity (V8 Peptides)
- HPLC vs. mass spectrometry (V8 Peptides)
- How to read a certificate of analysis (V8 Peptides)
- Third-party testing explained (V8 Peptides)
- Storing research peptides (V8 Peptides)
- How to reconstitute a lyophilized peptide (V8 Peptides)
- BPC-157 research vial (V8 Peptides product page)